Cerebrospinal Fluid Biomarkers and Reserve Variables as Predictors of Future “Non-Cognitive” Outcomes of Alzheimer’s Disease-Reference-Cited by-同舟云学术

Cerebrospinal Fluid Biomarkers and Reserve Variables as Predictors of Future “Non-Cognitive” Outcomes of Alzheimer’s Disease

Published:2016-05-23 Issue:3 Volume:52 Page:1055-1064
ISSN:1387-2877
Container-title:Journal of Alzheimer's Disease
language:
Short-container-title:JAD

Author:

Ingber Adam P.¹,Hassenstab Jason²³,Fagan Anne M.²⁴⁵,Benzinger Tammie L.S.²⁶⁷,Grant Elizabeth A.²,Holtzman David M.²⁴⁵⁸,Morris John C.²⁵⁹¹⁰¹¹,Roe Catherine M.²⁵

Affiliation:

1. Department of Biological Statistics and Computational Biology, Cornell University, Ithaca, NY, USA

2. Knight Alzheimer’s Disease Research Center, Washington University School of Medicine, St. Louis, MO, USA

3. Department of Psychological and Brain Sciences, Washington University School of Medicine, St. Louis, MO, USA

4. Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, MO, USA

5. Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA

6. Department of Radiology, Washington University School of Medicine, St. Louis, MO, USA

7. Department of Neurological Surgery, Washington University School of Medicine, St. Louis, MO, USA

8. Department of Molecular Biology and Pharmacology, Washington University School of Medicine, St. Louis, MO, USA

9. Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA

10. Department of Physical Therapy, Washington University School of Medicine, St. Louis, MO, USA

11. Department of Occupational Therapy, Washington University School of Medicine, St. Louis, MO, USA

Publisher

IOS Press

Subject

Psychiatry and Mental health,Geriatrics and Gerontology,Clinical Psychology,General Medicine,General Neuroscience

Reference42 articles.

1. Clinical and biomarker changes in dominantly inherited Alzheimer’s disease;Bateman;N Engl J Med,2012

2. Early-stage and preclinical Alzheimer disease;Morris;Alzheimer Dis Assoc Disord,2005

3. Regional variability of imaging biomarkers in autosomal dominant Alzheimer’s disease;Benzinger;Proc Natl Acad Sci U S A,2013

4. Fagan AM , Xiong C , Jasielec MS , Bateman RJ , Goate AM , Benzinger TLS , Ghetti B , Martins RN , Masters CL , Mayeux R , Ringman JM , Rossor MN , Salloway S , Schofield PR , Sperling RA , Marcus D , Cairns NJ , Buckles VD , Ladenson JH , Morris JC , Holtzman DM , Dominantly Inherited Alzheimer Network (2014) Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer’s disease. Sci Transl Med 6, 226ra30.

5. Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease;Sperling;Alzheimers Dement,2011

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of Preanalytical Cerebrospinal Fluid Handling and Storage Factors on Measurement of Aβ1-42, Aβ1-40, and pTau181 Using an Automated Chemiluminescent Platform;The Journal of Applied Laboratory Medicine;2024-05-07

2. The role of early cerebral edema and hematoma assessment in aneurysmal subarachnoid hemorrhage (a-SAH) in predicting structural brain abnormalities in cognitive impairments-- case controlled study;International Journal of Surgery;2024-03-05

3. The Role of Early Cerebral Edema and Hematoma assessment in Aneurysmal Subarachnoid Hemorrhage (a-SAH) in predicting Structural Brain Abnormalities in Cognitive Impairments;2023-12-07

4. Leveraging large multi-center cohorts of Alzheimer disease endophenotypes to understand the role of Klotho heterozygosity on disease risk;PLOS ONE;2022-05-26

5. Interaction between Cognitive Reserve and Biomarkers in Alzheimer Disease;International Journal of Molecular Sciences;2020-08-30